20 Jan

GSK Stockmann at the IBA’s 14th London Finance and Capital Markets Conference

09:00-18:00
London, UK
One Great George Street
London, SW1P 3AA, UK

GSK Stockmann will be at the IBA’s 14th London Finance and Capital Markets Conference – presented by the IBA Taxes Committee.

The conference addresses current trends and critical issues in finance, tax policy, and capital markets, with a focus on structured financing, tax compliance, and international developments. Topics include:

  • Half of the world voted in 2024: roundtable discussion
  • Impact of avoidance rules on investment income
  • Tax directors panel
  • Pillar 2
  • Securitisation transactions, what’s next after receivables and do taxes play a role
  • Cross border finance – how to structure in view of increasingly complex rules
  • Holding companies: state of play
  • Cross-border corporate restructurings
  • Spin offs and demergers: trends and traps
  • Private equity and funds
  • Navigating the stormy seas from an onslaught of transfer pricing audits and evolving transfer pricing rubrics
  • Tax litigation
  • Recent trends in M&A
  • ABC: AI, big data and crypto
  • Contested settlements and reliance on rulings + APA

Mathilde Ostertag (Partner at GSK Stockmann in Luxembourg) will be at the conference and speaking on a panel titled “Holding companies: state of play” – covering the following topics:

  • Best jurisdictions (fact vs fiction): Ireland, Luxembourg, Netherlands, Spain, the United Arab Emirates (UAE) and the UK
  • General anti-avoidance rules (GAARs) and specific anti-avoidance rules (SAARs) in the holding company context
  • Substance requirements: update on Unshell and domestic substance requirements in the UAE and US
  • US developments: treaty structures, status of the Trump tax reform and its impact on holding companies and the effect of Pillar 2

Further information about the conference and details how to register can be found here.

Contact person